84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]張維新,童培建.干細(xì)胞移植治療股骨頭壞死的研究進展[J].中醫(yī)正骨,2019,31(05):28-30.
點擊復(fù)制

干細(xì)胞移植治療股骨頭壞死的研究進展()
分享到：

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第31卷
期數(shù):
2019年05期
頁碼:
28-30
欄目:
綜 述
出版日期:
2019-05-20

文章信息/Info

作者:
張維新1; 童培建2
(1.浙江中醫(yī)藥大學(xué)第一臨床醫(yī)學(xué)院,浙江 杭州 310006; 2.浙江省中醫(yī)院,浙江 杭州 310006)
關(guān)鍵詞:
股骨頭壞死;  干細(xì)胞移植;  骨髓間充質(zhì)干細(xì)胞;  脂肪干細(xì)胞;  綜述
摘要:
股骨頭壞死的發(fā)病目前呈現(xiàn)出年輕化的趨勢,包括干細(xì)胞移植在內(nèi)的各種保髖療法成為了研究的熱點。骨髓間充質(zhì)干細(xì)胞和脂肪干細(xì)胞在股骨頭壞死的治療中應(yīng)用最為廣泛,常用的治療方式包括經(jīng)血管灌注、經(jīng)皮置管灌注及髓芯減壓灌注。干細(xì)胞移植主要是通過其旁分泌作用、增殖能力、分化能力,促進壞死區(qū)骨組織再生、血管再生,從而緩解髖關(guān)節(jié)癥狀、延緩股骨頭壞死進程。對于干細(xì)胞移植治療股骨頭壞死作用機制、細(xì)胞種類、細(xì)胞濃度及療程的研究,將有助于進一步提高該療法的療效和安全性。

參考文獻/References:

[1] COLOMB-LIPPA D.Avascular necrosis of the femoral head[J].JAAPA,2014,27(7):40-41. [2] 魯超,馬凰富,張兵,等.非創(chuàng)傷性股骨頭壞死的中醫(yī)證候特點研究[J].中華中醫(yī)藥雜志,2014,29(7):2189-2193. [3] ARBAB D,KÖNIG D P.Atraumatic femoral head necrosis in adults[J].Dtsch Arztebl Int,2016,113(3):31-38. [4] 朱蜀云,楊康,成向東,等.中醫(yī)療法治療中晚期非創(chuàng)傷性股骨頭壞死的研究[J].現(xiàn)代中西醫(yī)結(jié)合雜志,2018,27(4):357-360. [5] VILLA J C,HUSAIN S,VAN D J,et al.Treatment of pre-collapse stages of osteonecrosis of the femoral head:a systematic review of randomized control trials[J].HSS J,2016,12(3):261-271. [6] PAPAKOSTIDIS C,TOSOUNIDIS T H,JONES E,et al.The role of“cell therapy”in osteonecrosis of the femoral head.A systematic review of the literature and meta-analysis of 7 studies[J].Acta Orthop,2016,87(1):72-78. [7] SULTAN A A,KHLOPAS A,SURACE P,et al.The use of non-vascularized bone grafts to treat osteonecrosis of the femoral head:indications,techniques,and outcomes[J].Int Orthop,2019,43(6):1315-1320. [8] MAO Q,JIN H,LIAO F,et al.The efficacy of targeted intraarterial delivery of concentrated autologous bone marrow containing mononuclear cells in the treatment of osteonecrosis of the femoral head:a five year follow-up study[J].Bone,2013,57(2):509-516. [9] 李穎,董武.干細(xì)胞治療女性壓力性尿失禁研究進展[J].中國實用婦科與產(chǎn)科雜志,2011,27(5):398-400. [10] WYLES C C,HOUDEK M T,CRESPO-DIAZ R J,et al.Adipose-derived mesenchymal stem cells are phenotypically superior for regeneration in the setting of osteonecrosis of the femoral head[J].Clin Orthop Relat Res,2015,473(10):3080-3090. [11] MA Y,WANG T,LIAO J,et al.Efficacy of autologous bone marrow buffy coat grafting combined with core decompression in patients with avascular necrosis of femoral head:a prospective,double-blinded,randomized,controlled study[J].Stem Cell Res Ther,2014,5(5):115. [12] BECKMANN J,ROTH A,NIETHARD C,et al.Bone marrow edema and atraumatic necrosis of the femoral head:therapy[J].Orthopade,2015,44(9):662-671. [13] JIN H,XIA B,YU N,et al.The effects of autologous bone marrow mesenchymal stem cell arterial perfusion on vascular repair and angiogenesis in osteonecrosis of the femoral head in dogs[J].Int Orthop,2012,36(12):2589-2596. [14] MAO Q,WANG W,XU T,et al.Combination treatment of biomechanical support and targeted intra-arterial infusion of peripheral blood stem cells mobilized by granulocyte-colony stimulating factor for the osteonecrosis of the femoral head:a randomized controlled clinical trial[J].J Bone Miner Res,2015,30(4):647-656. [15] 陳興燦,劉淼,何東,等.經(jīng)皮置管術(shù)介入治療成人股骨頭壞死[J].功能與分子醫(yī)學(xué)影像學(xué)(電子版),2013,2(4):269-274. [16] ARBELOA-GUTIERREZ L,DEAN C S,CHAHLA J,et al.Core decompression augmented with autologous bone marrow aspiration concentrate for early avascular necrosis of the femoral head[J].Arthrosc Tech,2016,5(3):e615-e620. [17] PEPKE W,KASTEN P,BECKMANN N,et al.Core decompression and autologous bone marrow concentrate for treatment of femoral head osteonecrosis:a randomized prospective study[J].Orthop Rev(Pavia),2016,8(1):6162. [18] XU S,ZHANG L,JIN H,et al.Autologous stem cells combined core decompression for treatment of avascular necrosis of the femoral head:a systematic Meta-Analysis[J/OL].Biomed Res Int,2017[2019-03-01].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559921. [19] ZHAO D W,YU X B.Core decompression treatment of early-stage osteonecrosis of femoral head resulted from venous stasis or artery blood supply insufficiency[J].J Surg Res,2015,194(2):614-621. [20] LAU R L,PERRUCCIO A V,EVANS H M,et al.Stem cell therapy for the treatment of early stage avascular necrosis of the femoral head:a systematic review[J].BMC Musculoskelet Disord,2014,15:156. [21] YOSHIOKA T,MISHIMA H,AKAOGI H,et al.Concentrated autologous bone marrow aspirate transplantation treatment for corticosteroid-induced osteonecrosis of the femoral head in systemic lupus erythematosus[J].Int Orthop,2011,35(6):823-829. [22] GANGJI V,DE MAERTELAER V,HAUZEUR J P.Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head:Five year follow-up of a prospective controlled study[J].Bone,2011,49(5):1005-1009. [23] ZHAO D,CUI D,WANG B,et al.Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells[J].Bone,2012,50(1):325-330. [24] HANG D,WANG Q,GUO C,et al.Treatment of osteonecrosis of the femoral head with VEGF165 transgenic bone marrow mesenchymal stem cells in mongrel dogs[J].Cells Tissues Organs,2012,195(6):495-506. [25] SONG H J.Peripheral blood stem cell transplantation for ischemic femoral head necrosis[J].Transplant Proc,2010,42(5):1862-1864. [26] PIUZZI N S,CHAHLA J,SCHROCK J B,et al.Evidence for the use of Cell-Based therapy for the treatment of osteonecrosis of the femoral head:a systematic review of the literature[J].J Arthroplasty,2017,32(5):1698-1708. [27] CHEN C,QU Z G,YIN X G,et al.Efficacy of umbilical cord-derived mesenchymal stem cell-based therapy for osteonecrosis of the femoral head:A three-year follow-up study[J].Mol Med Rep,2016,14(5):4209-4215.[28] JIN H,XU T,CHEN Q,et al.The fate and distribution of autologous bone marrow mesenchymal stem cells with intra-arterial infusion in osteonecrosis of the femoral head in dogs[J/OL].Stem Cells Int,2016[2019-03-01].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686726. [29] JONES J P Jr.Fat embolism and osteonecrosis[J].Orthop Clin North Am,1985,16(4):595-633. [30] GANGJI V,HAUZEUR J P,SCHOUTENS A,et al.Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head[J].J Rheumatol,2003,30(2):348-351. [31] GANGJI V,HAUZEUR J P,MATOS C,et al.Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells.A pilot study[J].J Bone Joint Surg Am,2004,86(6):1153-1160.

相似文獻/References:

[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對兔股骨頭壞死模型 血管內(nèi)皮生長因子表達的動態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
　XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):1.
[3]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長因子和骨形態(tài)發(fā)生蛋白2 在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達[J].中醫(yī)正骨,2015,27(08):7.
　ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):7.
[4]鮑榮華,王國平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
　ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂郭氏正骨方藥藥物組成 最大頻繁關(guān)聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
　LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):21.
[7]李文龍,梅沉成,杜貴強,等.微創(chuàng)減壓植骨多孔鉭棒植入治療 ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預(yù)非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
　ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(05):14.
[9]鮑榮華,王國平,夏曉斌,等.直接前入路微創(chuàng)全髖關(guān)節(jié)置換術(shù)治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
　ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(05):20.
[11]朱海佳,周秋君,楊慧鳳,等.干細(xì)胞移植聯(lián)合髓芯減壓治療早中期股骨頭壞死的Meta分析[J].中醫(yī)正骨,2021,33(06):21.
　ZHU Haijia,ZHOU Qiujun,YANG Huifeng,et al.Stem cell transplantation combined with core decompression for treatment of early-middle osteonecrosis of the femoral head:a meta analysis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(05):21.

更新日期/Last Update: 2019-05-20